COVID-19 information, guidance, and resources. Information about campus return and fall quarter planning. Additional health guidance available on the CDC's COVID-19 site.
University of California, Riverside
NIH grant of $2.2 million could help researchers target two oncogenes, potentially leading to therapies for melanoma, lung cancer, and other tumors
UC Riverside-led study could lead to the development of drugs that target liver and other cancers
UC Riverside researchers develop new drugs that target therapeutically relevant protein surfaces
Surgery is associated with increased survival for patients with HER2-positive stage 4 breast cancer
Research highlights differences in risk among Asian American women who immigrated versus their U.S.-born counterparts
UC Riverside evolutionary biologist says increased cancer risk associated with height is due primarily to an increase in the number of body cells
Novel agents 135H11 and 135H12 move research closer to drug development
UC Riverside’s Maurizio Pellecchia receives grants totaling nearly $2.5 million from National Academy of Sciences, Engineering, and Medicine; and National Institute of Neurological Disorders and Stroke
A UCR research team has discovered a way for chemotherapy drug paclitaxel to target migrating cancer cells
UC Riverside-led study offers important information for understanding “de novo DNA methylation"